Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: We are waiting for the delegation from WHO to present the substances. I have the pleasure to invite Mr, to present substances: N-pyrrolidino isotonitazene and N-desethyl etonitazene to be placed in.Schedule I from the single …
Kuwait
Plenary — Wednesday afternoon session
Youth Forum: Your excellencies, distinguished delegates, ladies and gentleman. From 25 countries we gather as a unified voice to address the issue of substance use in our communities. This is not a new challenge and has been tackled over the past decades. Everyday there are new substances threatening individuals and society as a whole. It …
Item 6. Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem.
(…) UNODC: Thank you, Mr. Chair, distinguished delegates, ladies and gentlemen. It is my pleasure to brief the Commission on some of the significant efforts UNODC has undertaken over the last year to confront the global drug problem, in line with the Ministerial Declaration of 2019. Given time constraints, I will highlight just a few …
Item 3. High-level segment (Friday morning)
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …
Plenary: Item 4. General debate of the ministerial segment (cont…)
Brazil: We would like to associate ourselves with Egypt’s statement on behalf of the G77. Brazil welcomes the ministerial declaration renewing our global commitment to counter the WDP. As we reinforce international cooperation, we create an inducive environment. If we are to reach the strongest links of the drug market, we have to ensure criminals …
Plenary: Item 3 General Debate (Tuesday 13th – Morning Session)
Mexico: We meet because of our interest to tackle the World Drug Problem. Aware of the progress made so far, Mexico would like to strengthen the work of the CND in ordinary meetings, subsidiaries and intersessional. For Mexico it is important to replicate the good practice of this process. The implementation of the UNGASS document is …